OpenEvidence, an AI-powered medical search engine often described as 'ChatGPT for doctors,' was founded in Cambridge, Massachusetts in 2022 but relocated to Florida in 2025. The company specializes in analyzing peer-reviewed medical literature to assist physicians with diagnoses and treatment decisions, differentiating it from general-purpose AI tools. Backed by major investors including Google Ventures, Sequoia Capital, and Nvidia, OpenEvidence recently secured $250 million in new funding, bringing its valuation to $12 billion—the largest single funding round for a South Florida startup in the first quarter of 2026.

The company's expansion highlights a growing trend of tech startups moving to or scaling up in Florida, drawn by favorable business conditions and growing investor interest. OpenEvidence's technology is designed to improve clinical decision-making by rapidly synthesizing current medical research, a capability increasingly in demand as AI integrates deeper into healthcare systems. Its national medical society partnership suggests growing institutional trust in the platform.

While the tool is not intended to replace doctors, it aims to reduce diagnostic delays and keep practitioners updated with the latest evidence. The $12 billion valuation reflects strong market confidence, though widespread adoption will depend on integration with hospital systems, regulatory approvals, and clinician trust. The company has not disclosed specific deployment timelines beyond its Florida expansion.